AEON Biopharma logo

AEON Biopharma (AEON) Q3 2024 Earnings

AEON·Reported November 13, 2024·Before market open

Diluted EPS came in at $-11.51.

Diluted EPS
$-11.51met estimate
Consensus: $-11.51
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about AEON Biopharma's Q3 2024 earnings report.

AEON Biopharma (AEON) reported Q3 2024 earnings on November 13, 2024 before market open.

AEON Biopharma reported diluted EPS of $-11.51 for Q3 2024.

EPS beat the consensus estimate of $-11.51 by $0.00.

You can read the 10-Q periodic report (0001837607-24-000093) directly on SEC EDGAR. The filing index links above go to sec.gov.